| 1 | HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease. (Adler J, Galanko JA, Ammoury R, Benkov KJ, Bousvaros A, Boyle B, Cabrera JM, Chun KY, Dorsey J, Ebach DR, Firestine AM, Gulati AS, Herfarth HH, Jester TW, Kaplan JL, Leibowitz I, Linville TM, Margolis PA, Minar P, Molle-Rios Z, Moses J, Olano K, Pashankar DS, Pitch L, Saeed SA, Samson CM, Sandberg K, Steiner SJ, Strople JA, Sullivan JS, Wali PD, Kappelman MD) Am J Gastroenterol 2025 May 01;120(5):1076-1086 4 Citations |
| 2 | Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth. (Sun F, Cheng Y, Wanchai V, Guo W, Mery D, Xu H, Gai D, Siegel E, Bailey C, Ashby C, Al Hadidi S, Schinke C, Thanendrarajan S, Ma Y, Yi Q, Orlowski RZ, Zangari M, van Rhee F, Janz S, Bishop G, Tricot G, Shaughnessy JD Jr, Zhan F) Nat Commun 2024 Jan 19;15(1):615 44 Citations |
| 1 | World human neutrophil antigens investigation survey. (Bayat B, Lowack J, Audrain M, Croisille L, Curtis B, Dangerfield R, Esmaeili B, Grabowski C, Keller M, Kim H, Kroll H, Kvanka MM, Kwok J, Moritz E, Nathalang O, Nelson D, Nielsen KR, Pahn G, Poles A, Porcelijn L, Sachs UJ, Schönbacher M, Körmöczi GF, Kupatawintu P, Takahashi D, Uhrynowska M, Flesch B, Fung YL) Vox Sang 2023 Sep;118(9):763-774 4 Citations |
| 1 | Severe hemolytic disease of the newborn caused by JKb antibody: Two case reports and literature review. (Jiang LL, Bi SH, Yu J, Zhao FX, Teng M, Teng RJ) Medicine (Baltimore) 2023 Jul 28;102(30):e34390 4 Citations |
| 2 | HLA antibodies in fetal and neonatal alloimmune thrombocytopenia. (Colvin ZA, Schiller J, Tsaih SW, Sharma R, Grace RF, McIntosh JJ, Curtis BR) Transfusion 2023 Jun;63(6):1141-1149 7 Citations |
| 1 | Hemophilia a patients with inhibitors: Mechanistic insights and novel therapeutic implications. (Luo L, Zheng Q, Chen Z, Huang M, Fu L, Hu J, Shi Q, Chen Y) Front Immunol 2022;13:1019275 20 Citations |
| 1 | Cloned antibodies from patients with HIT provide new clues to HIT pathogenesis. (Zhu W, Zheng Y, Yu M, Wu Y, Wei J, Zhou L, Fu G, Schneider N, Jones C, Irani M, Padmanabhan A, Aster R, Wang D, Wen R) Blood 2023 Mar 02;141(9):1060-1069 8 Citations |
| 1 | αVEGFR2-MICA fusion antibodies enhance immunotherapy effect and synergize with PD-1 blockade. (Pan M, Wang F, Nan L, Yang S, Qi J, Xie J, Shao S, Zou H, Wang M, Sun F, Zhang J) Cancer Immunol Immunother 2023 Apr;72(4):969-984 18 Citations |
| 1 | Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies. (Kanack AJ, Jones CG, Singh B, Leger RR, Splinter NP, Heikal NM, Pruthi RK, Chen D, George G, Abou-Ismail MY, Wool GD, Gundabolu K, Padmanabhan A) Blood 2022 Dec 22;140(25):2722-2729 10 Citations |
| 5 | Validation of donor fraction cell-free DNA with biopsy-proven cardiac allograft rejection in children and adults. (Richmond ME, Deshpande SR, Zangwill SD, Bichell DP, Kindel SJ, Mahle WT, Schroder JN, Wigger MA, Knecht KR, Pahl E, Gaglianello NA, Goetsch MA, Simpson P, Dasgupta M, Zhang L, North PE, Tomita-Mitchell A, Mitchell ME) J Thorac Cardiovasc Surg 2023 Feb;165(2):460-468.e2 14 Citations |
| 1 | Optimized proximity ligation assay (PLA) for detection of RNA-protein complex interactions in cell lines. (George J, Mittal S, Kadamberi IP, Pradeep S, Chaluvally-Raghavan P) STAR Protoc 2022 Jun 17;3(2):101340 18 Citations |
| 1 | Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease. (Colman RJ, Xiong Y, Mizuno T, Hyams JS, Noe JD, Boyle B, D'Haens GR, van Limbergen J, Chun K, Yang J, Rosen MJ, Denson LA, Vinks AA, Minar P) Aliment Pharmacol Ther 2022 Mar;55(5):593-603 40 Citations |
| 1 | Are HPA-5b antibodies a significant cause of FNAIT and associated bleeding or merely an incidental finding? (Curtis BR) Br J Haematol 2021 Nov;195(4):485-486 3 Citations |
| 1 | Real-World Infliximab Pharmacokinetic Study Informs an Electronic Health Record-Embedded Dashboard to Guide Precision Dosing in Children with Crohn's Disease. (Xiong Y, Mizuno T, Colman R, Hyams J, Noe JD, Boyle B, Tsai YT, Dong M, Jackson K, Punt N, Rosen MJ, Denson LA, Vinks AA, Minar P) Clin Pharmacol Ther 2021 Jun;109(6):1639-1647 73 Citations |
| 1 | Trastuzumab-Induced Thrombocytopenia Correlated by Drug-Dependent Platelet Antibodies. (Sullivan K, Kaminer LS, Grinblatt DL, Campbell NP, Nocon CC, Harper AJ, Kang JH, Sarav M, Curtis BR, Brockstein BE) JCO Oncol Pract 2021 Mar;17(3):153-155 2 Citations |
| 1 | Measurement of Integrin Activation and Conformational Changes on the Cell Surface by Soluble Ligand and Antibody Binding Assays. (Wang Z, Zhu J) Methods Mol Biol 2021;2217:3-15 5 Citations |
| 1 | A prospective, blinded study of a PF4-dependent assay for HIT diagnosis. (Samuelson Bannow B, Warad DM, Jones CG, Pechauer SM, Curtis BR, Bougie DW, Sharma R, Grill DE, Redman MW, Khalighi PR, Leger RR, Pruthi RK, Chen D, Sabath DE, Aster RH, Garcia DA, Padmanabhan A) Blood 2021 Feb 25;137(8):1082-1089 44 Citations |
| 1 | Naturally occurring point mutation Cys460Trp located in the I-EGF1 domain of integrin β3 alters the binding of some anti-HPA-1a antibodies. (Holzwarth ST, Bayat B, Zhu J, Phuangtham R, Fischer L, Boeckelmann D, Röder L, Berghöfer H, Schmidt S, Bein G, Santoso S) Transfusion 2020 Sep;60(9):2097-2107 9 Citations |
| 1 | Platelet-Targeted FVIII Gene Therapy Restores Hemostasis and Induces Immune Tolerance for Hemophilia A. (Cai Y, Shi Q) Front Immunol 2020;11:964 7 Citations |
| 1 | Anti-myelin oligodendrocyte glycoprotein (MOG) associated disease masquerading as prolonged intractable nausea and vomiting. (Block A, Champeau D, Carlson C, Helms A, Obeidat AZ) Mult Scler Relat Disord 2020 Sep;44:102308 5 Citations |
| 1 | CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide. (Radhakrishnan SV, Luetkens T, Scherer SD, Davis P, Vander Mause ER, Olson ML, Yousef S, Panse J, Abdiche Y, Li KD, Miles RR, Matsui W, Welm AL, Atanackovic D) Nat Commun 2020 Feb 07;11(1):798 70 Citations |
| 1 | In Vivo Assessment of NK Cell-Mediated Cytotoxicity by Adoptively Transferred Splenocyte Rejection. (Schloemer NJ, Abel AM, Thakar MS, Malarkannan S) Methods Mol Biol 2020;2097:115-123 1 Citation |
| 2 | The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity. (Chen J, Schroeder JA, Luo X, Montgomery RR, Shi Q) J Thromb Haemost 2019 Mar;17(3):449-459 19 Citations |
| 2 | High-resolution mapping of the polyclonal immune response to the human platelet alloantigen HPA-1a (PlA1). (Zhi H, Ahlen MT, Thinn AMM, Weiler H, Curtis BR, Skogen B, Zhu J, Newman PJ) Blood Adv 2018 Nov 13;2(21):3001-3011 33 Citations |
| 1 | Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. (Chatterjee S, Chakraborty P, Daenthanasanmak A, Iamsawat S, Andrejeva G, Luevano LA, Wolf M, Baliga U, Krieg C, Beeson CC, Mehrotra M, Hill EG, Rathmell JC, Yu XZ, Kraft AS, Mehrotra S) Clin Cancer Res 2019 Feb 01;25(3):1036-1049 43 Citations |
| 1 | Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders. (Woolfrey A, Wang T, Lee SJ, Haagenson MD, Chen G, Fleischhauer K, Horan J, Hsu K, Verneris M, Spellman SR, Fernandez-Vina M) Bone Marrow Transplant 2019 Mar;54(3):494-496 10 Citations |
| 1 | Normal plasma IgG inhibits HIT antibody-mediated platelet activation: implications for therapeutic plasma exchange. (Jones CG, Pechauer SM, Curtis BR, Bougie DW, Aster RH, Padmanabhan A) Blood 2018 Feb 08;131(6):703-706 26 Citations |
| 2 | A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies. (Jones CG, Pechauer SM, Curtis BR, Bougie DW, Irani MS, Dhakal B, Pierce B, Aster RH, Padmanabhan A) Chest 2017 Oct;152(4):e77-e80 19 Citations |
| 1 | Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated. (Chen Y, Luo X, Schroeder JA, Chen J, Baumgartner CK, Hu J, Shi Q) J Thromb Haemost 2017 Oct;15(10):1994-2004 33 Citations |
| 1 | Anti-Neu5Gc and anti-non-Neu5Gc antibodies in healthy humans. (Gao B, Long C, Lee W, Zhang Z, Gao X, Landsittel D, Ezzelarab M, Ayares D, Huang Y, Cooper DKC, Wang Y, Hara H) PLoS One 2017;12(7):e0180768 52 Citations |
| 1 | Transplantation of hepatocytes from genetically engineered pigs into baboons. (Iwase H, Liu H, Schmelzer E, Ezzelarab M, Wijkstrom M, Hara H, Lee W, Singh J, Long C, Lagasse E, Gerlach JC, Cooper DKC, Gridelli B) Xenotransplantation 2017 Mar;24(2) 18 Citations |
| 1 | CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia. (Bajaj J, Konuma T, Lytle NK, Kwon HY, Ablack JN, Cantor JM, Rizzieri D, Chuah C, Oehler VG, Broome EH, Ball ED, van der Horst EH, Ginsberg MH, Reya T) Cancer Cell 2016 Nov 14;30(5):792-805 92 Citations |
| 1 | Eculizumab for Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: A Single-Center Experience. (Yelken B, Arpalı E, Görcin S, Kocak B, Karatas C, Demiralp E, Turkmen A) Transplant Proc 2015;47(6):1754-9 35 Citations |
| 1 | BAFF blockade prevents anti-drug antibody formation in a mouse model of Pompe disease. (Doerfler PA, Nayak S, Herzog RW, Morel L, Byrne BJ) Clin Immunol 2015 Jun;158(2):140-7 13 Citations |
| 1 | Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer. (Hong DS, Janku F, Naing A, Falchook GS, Piha-Paul S, Wheler JJ, Fu S, Tsimberidou AM, Stecher M, Mohanty P, Simard J, Kurzrock R) Invest New Drugs 2015 Jun;33(3):621-31 62 Citations |
| 1 | Endothelial PPAR-γ protects against vascular thrombosis by downregulating P-selectin expression. (Jin H, Gebska MA, Blokhin IO, Wilson KM, Ketsawatsomkron P, Chauhan AK, Keen HL, Sigmund CD, Lentz SR) Arterioscler Thromb Vasc Biol 2015 Apr;35(4):838-44 37 Citations |
| 1 | Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. (Reese JA, Bougie DW, Curtis BR, Terrell DR, Vesely SK, Aster RH, George JN) Am J Hematol 2015 May;90(5):406-10 102 Citations |
| 1 | A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression. (Bloom DD, Centanni JM, Bhatia N, Emler CA, Drier D, Leverson GE, McKenna DH Jr, Gee AP, Lindblad R, Hei DJ, Hematti P) Cytotherapy 2015 Feb;17(2):140-51 81 Citations |
| 2 | Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis. (Padmanabhan A, Jones CG, Bougie DW, Curtis BR, McFarland JG, Wang D, Aster RH) Blood 2015 Jan 01;125(1):155-61 80 Citations |
| 1 | Regulation of endothelial cell barrier function by antibody-driven affinity modulation of platelet endothelial cell adhesion molecule-1 (PECAM-1). (Mei H, Campbell JM, Paddock CM, Lertkiatmongkol P, Mosesson MW, Albrecht R, Newman PJ) J Biol Chem 2014 Jul 25;289(30):20836-44 29 Citations |
| 1 | Quantifying the risk of incompatible kidney transplantation: a multicenter study. (Orandi BJ, Garonzik-Wang JM, Massie AB, Zachary AA, Montgomery JR, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL) Am J Transplant 2014 Jul;14(7):1573-80 182 Citations |
| 1 | Toxicity of targeted therapy: Implications for response and impact of genetic polymorphisms. (Liu S, Kurzrock R) Cancer Treat Rev 2014 Aug;40(7):883-91 155 Citations |
| 1 | S100A proteins as molecular targets in the ocular surface inflammatory diseases. (Tong L, Lan W, Lim RR, Chaurasia SS) Ocul Surf 2014 Jan;12(1):23-31 96 Citations |
| 1 | A study of prospective surveillance for inhibitors among persons with haemophilia in the United States. (Soucie JM, Miller CH, Kelly FM, Payne AB, Creary M, Bockenstedt PL, Kempton CL, Manco-Johnson MJ, Neff AT, Haemophilia Inhibitor Research Study Investigators) Haemophilia 2014 Mar;20(2):230-7 34 Citations |
| 1 | Sensitization from transfusion in patients awaiting primary kidney transplant. (Yabu JM, Anderson MW, Kim D, Bradbury BD, Lou CD, Petersen J, Rossert J, Chertow GM, Tyan DB) Nephrol Dial Transplant 2013 Nov;28(11):2908-18 82 Citations |
| 1 | Effects of interleukin-6 on the expression of tight junction proteins in isolated cerebral microvessels from yearling and adult sheep. (Cohen SS, Min M, Cummings EE, Chen X, Sadowska GB, Sharma S, Stonestreet BS) Neuroimmunomodulation 2013;20(5):264-73 67 Citations |
| 1 | Antibodies and activity measurements for the detection of O-GlcNAc transferase and assay of its substrate, UDP-GlcNAc. (Lefebvre T, Drougat L, Olivier-Van Stichelen S, Michalski JC, Vercoutter-Edouart AS) Methods Mol Biol 2013;1022:147-59 6 Citations |
| 2 | Donor and recipient BKV-specific IgG antibody and posttransplantation BKV infection: a prospective single-center study. (Sood P, Senanayake S, Sujeet K, Medipalli R, Van-Why SK, Cronin DC, Johnson CP, Hariharan S) Transplantation 2013 Mar 27;95(6):896-902 51 Citations |
| 1 | Pleiotrophin regulates the retention and self-renewal of hematopoietic stem cells in the bone marrow vascular niche. (Himburg HA, Harris JR, Ito T, Daher P, Russell JL, Quarmyne M, Doan PL, Helms K, Nakamura M, Fixsen E, Herradon G, Reya T, Chao NJ, Harroch S, Chute JP) Cell Rep 2012 Oct 25;2(4):964-75 95 Citations |
| 2 | Factor VIII inhibitors: von Willebrand factor makes a difference in vitro and in vivo. (Shi Q, Kuether EL, Schroeder JA, Perry CL, Fahs SA, Cox Gill J, Montgomery RR) J Thromb Haemost 2012 Nov;10(11):2328-37 25 Citations |
| 1 | Future preventive and therapeutic targets for transfusion-related acute lung injury. (Curtis BR) Curr Pharm Des 2012;18(22):3285-92 2 Citations |
| 3 | Requirements for growth and IL-10 expression of highly purified human T regulatory cells. (Bonacci B, Edwards B, Jia S, Williams CB, Hessner MJ, Gauld SB, Verbsky JW) J Clin Immunol 2012 Oct;32(5):1118-28 12 Citations |
| 1 | Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin. (Bougie DW, Rasmussen M, Zhu J, Aster RH) Blood 2012 Jun 28;119(26):6317-25 39 Citations |
| 1 | Degradation of internalized αvβ5 integrin is controlled by uPAR bound uPA: effect on β1 integrin activity and α-SMA stress fiber assembly. (Wang L, Pedroja BS, Meyers EE, Garcia AL, Twining SS, Bernstein AM) PLoS One 2012;7(3):e33915 25 Citations |
| 1 | Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance. (Miller CH, Platt SJ, Rice AS, Kelly F, Soucie JM, Hemophilia Inhibitor Research Study Investigators) J Thromb Haemost 2012 Jun;10(6):1055-61 108 Citations |
| 1 | Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease. (Messinger YH, Mendelsohn NJ, Rhead W, Dimmock D, Hershkovitz E, Champion M, Jones SA, Olson R, White A, Wells C, Bali D, Case LE, Young SP, Rosenberg AS, Kishnani PS) Genet Med 2012 Jan;14(1):135-42 206 Citations |
| 2 | Correction of murine Bernard-Soulier syndrome by lentivirus-mediated gene therapy. (Kanaji S, Kuether EL, Fahs SA, Schroeder JA, Ware J, Montgomery RR, Shi Q) Mol Ther 2012 Mar;20(3):625-32 32 Citations |
| 1 | Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866). (Kurtzberg J, Asselin B, Bernstein M, Buchanan GR, Pollock BH, Camitta BM) J Pediatr Hematol Oncol 2011 Dec;33(8):610-6 53 Citations |
| 2 | Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. (Soiffer RJ, Lerademacher J, Ho V, Kan F, Artz A, Champlin RE, Devine S, Isola L, Lazarus HM, Marks DI, Porter DL, Waller EK, Horowitz MM, Eapen M) Blood 2011 Jun 23;117(25):6963-70 321 Citations |
| 1 | Isolation and culture of pulmonary endothelial cells from neonatal mice. (Sobczak M, Dargatz J, Chrzanowska-Wodnicka M) J Vis Exp 2010 Dec 14(46) 89 Citations |
| 1 | Another blow to leukocyte antibody-mediated TRALI. (Curtis BR) Expert Rev Hematol 2010 Aug;3(4):373-5 2 Citations |
| 1 | P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease. (Polanowska-Grabowska R, Wallace K, Field JJ, Chen L, Marshall MA, Figler R, Gear AR, Linden J) Arterioscler Thromb Vasc Biol 2010 Dec;30(12):2392-9 167 Citations |
| 1 | 4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. (Wool GD, Cabana VG, Lukens J, Shaw PX, Binder CJ, Witztum JL, Reardon CA, Getz GS) FASEB J 2011 Jan;25(1):290-300 45 Citations |
| 1 | Promoter-specific lentivectors for long-term, cardiac-directed therapy of Fabry disease. (Lee CJ, Fan X, Guo X, Medin JA) J Cardiol 2011 Jan;57(1):115-22 38 Citations |
| 1 | Homogeneous insulin and C-Peptide sensors for rapid assessment of insulin and C-peptide secretion by the islets. (Heyduk E, Moxley MM, Salvatori A, Corbett JA, Heyduk T) Diabetes 2010 Oct;59(10):2360-5 41 Citations |
| 2 | Targeting FVIII expression to endothelial cells regenerates a releasable pool of FVIII and restores hemostasis in a mouse model of hemophilia A. (Shi Q, Fahs SA, Kuether EL, Cooley BC, Weiler H, Montgomery RR) Blood 2010 Oct 21;116(16):3049-57 45 Citations |
| 1 | Evaluation of factor VIII pharmacokinetics and anti-factor VIII antibodies in four boys with haemophilia A and a poor clinical response to factor VIII. (Kempton CL, Meeks SL, Donald Harvey R 3rd, Abshire TC) Haemophilia 2011 Jan;17(1):155-6 8 Citations |
| 1 | Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. (Reese JA, Li X, Hauben M, Aster RH, Bougie DW, Curtis BR, George JN, Vesely SK) Blood 2010 Sep 23;116(12):2127-33 132 Citations |
| 1 | Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's disease. (Ippoliti A, Devlin S, Mei L, Yang H, Papadakis KA, Vasiliauskas EA, McGovern DP, Abreu MT, Melmed G, Shaye O, Enayati P, Chen G, Choi J, Taylor K, Landers CJ, Rotter JI, Targan SR) Inflamm Bowel Dis 2010 Aug;16(8):1279-85 28 Citations |
| 1 | Glomerular protein levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 are lower in diabetic subjects. (Cornish TC, Bagnasco SM, Macgregor AM, Lu J, Selvin E, Halushka MK) J Histochem Cytochem 2009 Nov;57(11):995-1001 11 Citations |
| 2 | Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. (Chen X, Das R, Komorowski R, Beres A, Hessner MJ, Mihara M, Drobyski WR) Blood 2009 Jul 23;114(4):891-900 271 Citations |
| 1 | Inhibitors of factor VIII in black patients with hemophilia. (Viel KR, Ameri A, Abshire TC, Iyer RV, Watts RG, Lutcher C, Channell C, Cole SA, Fernstrom KM, Nakaya S, Kasper CK, Thompson AR, Almasy L, Howard TE) N Engl J Med 2009 Apr 16;360(16):1618-27 170 Citations |
| 1 | Molecular imaging of Bcr-Abl phosphokinase in a xenograft model. (Wu JY, Yang DJ, Angelo LS, Kohanim S, Kurzrock R) Mol Cancer Ther 2009 Mar;8(3):703-10 5 Citations |
| 2 | Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain. (Gao C, Boylan B, Bougie D, Gill JC, Birenbaum J, Newman DK, Aster RH, Newman PJ) J Clin Invest 2009 Mar;119(3):504-11 59 Citations |
| 1 | Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia. (Ghevaert C, Wilcox DA, Fang J, Armour KL, Clark MR, Ouwehand WH, Williamson LM) J Clin Invest 2008 Aug;118(8):2929-38 47 Citations |
| 1 | TGF-beta-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis. (Wang H, Peters T, Sindrilaru A, Kess D, Oreshkova T, Yu XZ, Seier AM, Schreiber H, Wlaschek M, Blakytny R, Röhrbein J, Schulz G, Weiss JM, Scharffetter-Kochanek K) J Clin Invest 2008 Jul;118(7):2629-39 61 Citations |
| 1 | Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice. (Mukhopadhaya A, Hanafusa T, Jarchum I, Chen YG, Iwai Y, Serreze DV, Steinman RM, Tarbell KV, DiLorenzo TP) Proc Natl Acad Sci U S A 2008 Apr 29;105(17):6374-9 124 Citations |
| 1 | Neonatal alloimmune thrombocytopenia associated with maternal-fetal incompatibility for blood group B. (Curtis BR, Fick A, Lochowicz AJ, McFarland JG, Ball RH, Peterson J, Aster RH) Transfusion 2008 Feb;48(2):358-64 46 Citations |
| 1 | Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. (Xing Y, Chaudry Q, Shen C, Kong KY, Zhau HE, Chung LW, Petros JA, O'Regan RM, Yezhelyev MV, Simons JW, Wang MD, Nie S) Nat Protoc 2007;2(5):1152-65 499 Citations |
| 3 | Prevalence of heparin-dependent platelet antibodies in children after cardiopulmonary bypass. (Hanson SJ, Punzalan RC, Ghanayem N, Havens P) Pediatr Crit Care Med 2007 Jul;8(4):358-61 13 Citations |
| 1 | Anti-CD25 targeted killing of bicistronically transduced cells: a novel safety mechanism against retroviral genotoxicity. (Ramsubir S, Yoshimitsu M, Medin JA) Mol Ther 2007 Jun;15(6):1174-81 8 Citations |
| 1 | Vancomycin-induced immune thrombocytopenia. (Von Drygalski A, Curtis BR, Bougie DW, McFarland JG, Ahl S, Limbu I, Baker KR, Aster RH) N Engl J Med 2007 Mar 01;356(9):904-10 184 Citations |
| 4 | Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A. (Shi Q, Wilcox DA, Fahs SA, Fang J, Johnson BD, DU LM, Desai D, Montgomery RR) J Thromb Haemost 2007 Feb;5(2):352-61 124 Citations |
| 3 | Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies. (Shi Q, Wilcox DA, Fahs SA, Weiler H, Wells CW, Cooley BC, Desai D, Morateck PA, Gorski J, Montgomery RR) J Clin Invest 2006 Jul;116(7):1974-82 166 Citations |
| 1 | Developmental changes in the expression of GABAA receptor subunits alpha1, alpha2, and alpha3 in brain stem nuclei of rats. (Liu Q, Wong-Riley MT) Brain Res 2006 Jul 07;1098(1):129-38 65 Citations |
| 1 | Conduction system disease in fetuses evaluated for irregular cardiac rhythm. (Cuneo BF, Strasburger JF, Wakai RT, Ovadia M) Fetal Diagn Ther 2006;21(3):307-13 52 Citations |
| 1 | Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs? (White GC 2nd, Kempton CL, Grimsley A, Nielsen B, Roberts HR) J Thromb Haemost 2005 Aug;3(8):1676-81 76 Citations |
| 1 | Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. (Montano SM, Villaran MV, Ylquimiche L, Figueroa JJ, Rodriguez S, Bautista CT, Gonzalez AE, Tsang VC, Gilman RH, Garcia HH, Cysticercosis Working Group in Peru) Neurology 2005 Jul 26;65(2):229-33 211 Citations |
| 1 | Intrabody applications in neurological disorders: progress and future prospects. (Miller TW, Messer A) Mol Ther 2005 Sep;12(3):394-401 77 Citations |
| 1 | C-kit receptor and its possible function in human spermatozoa. (Feng HL, Sandlow JI, Zheng LJ) Mol Reprod Dev 2005 Jan;70(1):103-10 15 Citations |
| 1 | CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens. (Yu XZ, Albert MH, Martin PJ, Anasetti C) J Clin Invest 2004 Jun;113(11):1624-30 58 Citations |
| 1 | Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug. (Curtis BR, Divgi A, Garritty M, Aster RH) J Thromb Haemost 2004 Jun;2(6):985-92 81 Citations |
| 1 | Protein methylation activates reconstituted ryanodine receptor-ca release channels from coronary artery myocytes. (Chen YF, Zhang AY, Zou AP, Campbell WB, Li PL) J Vasc Res 2004;41(3):229-40 21 Citations |
| 1 | Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia. (Kiem HP, Sellers S, Thomasson B, Morris JC, Tisdale JF, Horn PA, Hematti P, Adler R, Kuramoto K, Calmels B, Bonifacino A, Hu J, von Kalle C, Schmidt M, Sorrentino B, Nienhuis A, Blau CA, Andrews RG, Donahue RE, Dunbar CE) Mol Ther 2004 Mar;9(3):389-95 86 Citations |
| 1 | Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation. (Kaufman DB, Burke GW III, Bruce DS, Johnson CP, Gaber AO, Sutherland DE, Merion RM, Gruber SA, Schweitzer E, Leone JP, Marsh CL, Alfrey E, Concepcion W, Stegall MD, Schulak JA, Gores PF, Benedetti E, Smith C, Henning AK, Kuehnel F, King S, Fitzsimmons WE) Am J Transplant 2003 Jul;3(7):855-64 59 Citations |
| 1 | TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. (Davoren A, Curtis BR, Shulman IA, Mohrbacher AF, Bux J, Kwiatkowska BJ, McFarland JG, Aster RH) Transfusion 2003 May;43(5):641-5 150 Citations |
| 1 | Development of enzyme immunoassays for 5,6-, 8,9-, 11,12-, and 14,15- EETs and the corresponding DHETs. (Sasaki DM, Yuan Y, Gikas K, Reddy M, Falck JR, Nithipatikom K, Campbell WB, Callewaert DM) Adv Exp Med Biol 2002;507:531-6 3 Citations |
| 1 | Neutralization of IL-18 attenuates lipopolysaccharide-induced myocardial dysfunction. (Raeburn CD, Dinarello CA, Zimmerman MA, Calkins CM, Pomerantz BJ, McIntyre RC Jr, Harken AH, Meng X) Am J Physiol Heart Circ Physiol 2002 Aug;283(2):H650-7 74 Citations |
| 1 | ICAM-1 and VCAM-1 mediate endotoxemic myocardial dysfunction independent of neutrophil accumulation. (Raeburn CD, Calkins CM, Zimmerman MA, Song Y, Ao L, Banerjee A, Harken AH, Meng X) Am J Physiol Regul Integr Comp Physiol 2002 Aug;283(2):R477-86 83 Citations |
| 1 | Role of FKBP12.6 in cADPR-induced activation of reconstituted ryanodine receptors from arterial smooth muscle. (Tang WX, Chen YF, Zou AP, Campbell WB, Li PL) Am J Physiol Heart Circ Physiol 2002 Apr;282(4):H1304-10 94 Citations |
| 1 | Rh genotyping: avoiding false-negative and false-positive results among individuals of African ancestry. (Ekman GC, Billingsly R, Hessner MJ) Am J Hematol 2002 Jan;69(1):34-40 14 Citations |
| 1 | Analysis of Cdc6 function in the assembly of mammalian prereplication complexes. (Cook JG, Park CH, Burke TW, Leone G, DeGregori J, Engel A, Nevins JR) Proc Natl Acad Sci U S A 2002 Feb 05;99(3):1347-52 104 Citations |
| 1 | Additive effects of anti-CD3 and anti-CD28 prolongation of allogeneic skin graft survival. (Yu XZ, Nitta Y, Bidwell SJ, Anasetti C) Transplantation 2001 Dec 15;72(11):1862 1 Citation |
| 1 | Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training. (Amaral SL, Papanek PE, Greene AS) Am J Physiol Heart Circ Physiol 2001 Sep;281(3):H1163-9 140 Citations |
| 1 | Vascular cell adhesion molecule--1 expression is obligatory for endotoxin-induced myocardial neutrophil accumulation and contractile dysfunction. (Raeburn CD, Calkins CM, Zimmerman MA, Song Y, Ao L, Banerjee A, Meng X, Harken AH) Surgery 2001 Aug;130(2):319-25 44 Citations |
| 1 | The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. (Liu Z, Zhou X, Shapiro SD, Shipley JM, Twining SS, Diaz LA, Senior RM, Werb Z) Cell 2000 Sep 01;102(5):647-55 363 Citations |
| 1 | Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy--International Kogenate-FS Study Group. (Abshire TC, Brackmann HH, Scharrer I, Hoots K, Gazengel C, Powell JS, Gorina E, Kellermann E, Vosburgh E) Thromb Haemost 2000 Jun;83(6):811-6 128 Citations |
| 1 | Follicle selection in cyclic guinea pigs with active immunization against inhibin alpha-subunit. (Shi F, Mochida K, Ogura A, Matsuda J, Suzuki O, Watanabe G, Hutz RJ, Tsonis CG, Suzuki AK, Taya K) Life Sci 2000;66(25):2489-97 6 Citations |
| 1 | The Pitx2 protein in mouse development. (Hjalt TA, Semina EV, Amendt BA, Murray JC) Dev Dyn 2000 May;218(1):195-200 124 Citations |
| 1 | A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation. (Nash RA, Kurzrock R, DiPersio J, Vose J, Linker C, Maharaj D, Nademanee AP, Negrin R, Nimer S, Shulman H, Ashby M, Jones D, Appelbaum FR, Champlin R) Biol Blood Marrow Transplant 2000;6(1):25-34 83 Citations |
| 1 | Enhancement of susceptibility to Fas-mediated apoptosis of TH1 cells by nonmitogenic anti-CD3epsilon F(ab')2. (Yu XZ, Anasetti C) Transplantation 2000 Jan 15;69(1):104-12 16 Citations |
| 1 | Cooperation of fibronectin with lysophosphatidic acid induces motility and transcellular migration of rat ascites hepatoma cells. (Ayaki M, Mukai M, Imamura F, Iwasaki T, Mammoto T, Shinkai K, Nakamura H, Akedo H) Biochim Biophys Acta 2000 Jan 10;1495(1):40-50 21 Citations |
| 1 | Chronic salt loading and the expression of adenosine receptor subtypes. (Nayeem MA, Olanrewaju HA, Mustafa SJ, Li PL, Cowley AW Jr) Hypertension 1999 Dec;34(6):e18-9 3 Citations |
| 1 | Enhanced expression of the cytoskeleton-associated proteins paxillin and focal adhesion kinase in glomerular immune injury. (Koukouritaki SB, Tamizuddin A, Lianos EA) J Lab Clin Med 1999 Aug;134(2):173-9 12 Citations |
| 1 | Reduction of myocardial infarct size after ischemia and reperfusion by the glycosaminoglycan pentosan polysulfate. (Tanhehco EJ, Kilgore KS, Naylor KB, Park JL, Booth EA, Lucchesi BR) J Cardiovasc Pharmacol 1999 Jul;34(1):153-61 34 Citations |
| 2 | Pre-transplant identification of risk factors that adversely affect length of stay and charges for renal transplantation. (Johnson CP, Kuhn EM, Hariharan S, Hartz AJ, Roza AM, Adams MB) Clin Transplant 1999 Apr;13(2):168-75 53 Citations |
| 1 | Kidney is the only source of human plasma renin in 45-kb human renin transgenic mice. (Yan Y, Chen R, Pitarresi T, Sigmund CD, Gross KW, Sealey JE, Laragh JH, Catanzaro DF) Circ Res 1998 Dec 14-28;83(12):1279-88 27 Citations |
| 1 | Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment. (Drobyski WR, Majewski D, Ozker K, Hanson G) J Immunol 1998 Sep 01;161(5):2610-9 48 Citations |
| 1 | Repetitive coronary artery occlusions induce release of growth factors into the myocardial interstitium. (Weihrauch D, Tessmer J, Warltier DC, Chilian WM) Am J Physiol 1998 Sep;275(3):H969-76 41 Citations |
| 1 | Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection. (Moallem HJ, Garratty G, Wakeham M, Dial S, Oligario A, Gondi A, Rao SP, Fikrig S) J Pediatr 1998 Aug;133(2):279-81 40 Citations |
| 1 | Isolation of a rat histidase cDNA sequence and expression in Escherichia coli--evidence of extrahepatic/epidermal distribution. (Sano H, Tada T, Moriyama A, Ogawa H, Asai K, Kawai Y, Hodgson ME, Kato T, Wada Y, Suchi M) Eur J Biochem 1997 Nov 15;250(1):212-21 12 Citations |
| 1 | Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein. (Li PL, Campbell WB) Circ Res 1997 Jun;80(6):877-84 234 Citations |
| 2 | Determination of 14,15-epoxyeicosatrienoic acid and 14,15-dihydroxyeicosatrienoic acid by fluoroimmunoassay. (Nithipatikom K, Falck JR, Bhatt RK, Hanke CJ, Campbell WB) Anal Biochem 1997 Mar 15;246(2):253-9 11 Citations |
| 1 | Protective role of nerve growth factor against postischemic dysfunction of sympathetic coronary innervation. (Abe T, Morgan DA, Gutterman DD) Circulation 1997 Jan 07;95(1):213-20 81 Citations |
| 1 | L-amino acid oxidase (LOX) modulation of melphalan activity against intracranial glioma. (Moynihan K, Elion GB, Pegram C, Reist CJ, Wellner D, Bigner DD, Griffith OW, Friedman HS) Cancer Chemother Pharmacol 1997;39(3):179-86 7 Citations |
| 1 | Molecular and biologic characterization of a newly established Philadelphia-positive acute lymphoblastic leukemia cell line (Z-33) with an autocrine response to GM-CSF. (Estrov Z, Talpaz M, Ku S, Harris D, LaPushin R, Koller CA, Hirsh-Ginsberg C, Huh Y, Yee G, Kurzrock R) Leukemia 1996 Sep;10(9):1534-43 17 Citations |
| 1 | Delayed-type hypersensitivity in mast cell-deficient mice: dependence on platelets for expression of contact sensitivity. (Geba GP, Ptak W, Anderson GM, Paliwal V, Ratzlaff RE, Levin J, Askenase PW) J Immunol 1996 Jul 15;157(2):557-65 89 Citations |
| 2 | Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes. (Alkayed NJ, Narayanan J, Gebremedhin D, Medhora M, Roman RJ, Harder DR) Stroke 1996 May;27(5):971-9 183 Citations |
| 1 | Localization of authentic thromboxane A2/prostaglandin H2 receptor in the rat kidney. (Bresnahan BA, Le Breton GC, Lianos EA) Kidney Int 1996 May;49(5):1207-13 25 Citations |
| 1 | A unique ectonucleotide pyrophosphohydrolase associated with porcine chondrocyte-derived vesicles. (Masuda I, Hamada J, Haas AL, Ryan LM, McCarty DJ) J Clin Invest 1995 Feb;95(2):699-704 29 Citations |
| 1 | Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex. (Curtis BR, McFarland JG, Wu GG, Visentin GP, Aster RH) Blood 1994 Jul 01;84(1):176-83 123 Citations |
| 1 | A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. (Goodnough LT, Price TH, Friedman KD, Johnston M, Ciavarella D, Khan N, Sacher R, Vogler WR, Wissel M, Abels RI) Transfusion 1994 Jan;34(1):66-71 117 Citations |
| 1 | Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. (Visentin GP, Ford SE, Scott JP, Aster RH) J Clin Invest 1994 Jan;93(1):81-8 566 Citations |
| 1 | A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity. (Rivera VM, Miranti CK, Misra RP, Ginty DD, Chen RH, Blenis J, Greenberg ME) Mol Cell Biol 1993 Oct;13(10):6260-73 246 Citations |
| 1 | Aggregation-induced activation of the epidermal growth factor receptor protein tyrosine kinase. (Mohammadi M, Honegger A, Sorokin A, Ullrich A, Schlessinger J, Hurwitz DR) Biochemistry 1993 Aug 31;32(34):8742-8 55 Citations |
| 1 | Inhibition of precardiac mesoderm cell proliferation by antisense oligodeoxynucleotide complementary to fibroblast growth factor-2 (FGF-2). (Sugi Y, Sasse J, Lough J) Dev Biol 1993 May;157(1):28-37 86 Citations |
| 1 | Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines. (Estrov Z, Kurzrock R, Pocsik E, Pathak S, Kantarjian HM, Zipf TF, Harris D, Talpaz M, Aggarwal BB) J Exp Med 1993 Mar 01;177(3):763-74 84 Citations |
| 1 | [The production and characteristics of polyclonal antibodies to the threonine-containing site of the cytoplasmic domain of the EGF receptor]. (Sorokin AB, Aleksandrov KE, Vinogradova NA, Nesterov AM, Nikol'skiĭ NN) Tsitologiia 1993;35(4):68-72 1 Citation |
| 1 | Stroke in an early adolescent with systemic lupus erythematosus and coexistent antiphospholipid antibodies. (Dungan DD, Jay MS) Pediatrics 1992 Jul;90(1 Pt 1):96-9 23 Citations |
| 1 | Anti-tumor necrosis factor antibody augments edema formation in caerulein-induced acute pancreatitis. (Guice KS, Oldham KT, Remick DG, Kunkel SL, Ward PA) J Surg Res 1991 Dec;51(6):495-9 76 Citations |
| 1 | The serum response factor is extensively modified by phosphorylation following its synthesis in serum-stimulated fibroblasts. (Misra RP, Rivera VM, Wang JM, Fan PD, Greenberg ME) Mol Cell Biol 1991 Sep;11(9):4545-54 87 Citations |
| 1 | [The capping of receptors for the epidermal growth factor and the participation of the cytoskeleton in this process in A-431 cells]. (Khrebtukova IA, Nikol'skaia AN, Sorkin AD, Sorokin AB, Pinaev GP) Tsitologiia 1989 Oct;31(10):1211-20 1 Citation |
| 1 | Antipeptide antibodies to the beta 2-adrenergic receptor confirm the extracellular orientation of the amino-terminus and the putative first extracellular loop. (Théveniau MA, Raymond JR, Rougon GN) J Membr Biol 1989 Oct;111(2):141-53 5 Citations |
| 1 | Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. (Connor TB Jr, Roberts AB, Sporn MB, Danielpour D, Dart LL, Michels RG, de Bustros S, Enger C, Kato H, Lansing M) J Clin Invest 1989 May;83(5):1661-6 477 Citations |
| 1 | Intracellular fusion of sequentially formed endocytic compartments. (Salzman NH, Maxfield FR) J Cell Biol 1988 Apr;106(4):1083-91 60 Citations |
| 1 | Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. II. Use of detergents and antibodies. (Woeltje KF, Kuwajima M, Foster DW, McGarry JD) J Biol Chem 1987 Jul 15;262(20):9822-7 121 Citations |
| 1 | C-reactive protein is involved in natural killer cell-mediated lysis but does not mediate effector-target cell recognition. (Baum LL, Johnson B, Berman S, Graham D, Mold C) Immunology 1987 May;61(1):93-9 19 Citations |
| 1 | Cell adherence to microfilariae of Onchocerca volvulus: a comparative study. (Williams JF, Ghalib HW, Mackenzie CD, Elkhalifa MY, Ayuya JM, Kron MA) Ciba Found Symp 1987;127:146-63 15 Citations |
| 1 | Phase I study of i.v. administered recombinant gamma interferon in cancer patients. (Kurzrock R, Quesada JR, Rosenblum MG, Sherwin SA, Gutterman JU) Cancer Treat Rep 1986 Dec;70(12):1357-64 36 Citations |
| 1 | Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients. (Kurzrock R, Rosenblum MG, Quesada JR, Sherwin SA, Itri LM, Gutterman JU) J Clin Oncol 1986 Nov;4(11):1677-83 46 Citations |
| 1 | Phase I study of multiple dose intramuscularly administered recombinant gamma interferon. (Kurzrock R, Quesada JR, Talpaz M, Hersh EM, Reuben JM, Sherwin SA, Gutterman JU) J Clin Oncol 1986 Jul;4(7):1101-9 81 Citations |
| 1 | Thrombospondin: a versatile multifunctional glycoprotein. (Silverstein RL, Leung LL, Nachman RL) Arteriosclerosis 1986;6(3):245-53 55 Citations |
| 1 | Use of monoclonal antibody to increase the sensitivity and specificity of precipitating immunoassays and cell surface binding immunoassays. (Montgomery RR, Kunicki TJ, Glode LM) Methods Enzymol 1986;121:702-17 10 Citations |
| 1 | Membrane assembly in retinal photoreceptors. III. Distinct membrane domains of the connecting cilium of developing rods. (Besharse JC, Forestner DM, Defoe DM) J Neurosci 1985 Apr;5(4):1035-48 86 Citations |
| 1 | Membrane assembly in retinal photoreceptors. II. Immunocytochemical analysis of freeze-fractured rod photoreceptor membranes using anti-opsin antibodies. (Defoe DM, Besharse JC) J Neurosci 1985 Apr;5(4):1023-34 25 Citations |
| 1 | Failure of activated prothrombin complex concentrates in a hemophiliac with an anti-factor VIII antibody. (Blatt PM, White GC 2nd, McMillan CW, Webster WP) JAMA 1984 Jan 06;251(1):67 10 Citations |
| 1 | Use of immunoadsorbents for the study of antibody binding to sperm whale myoglobin and its synthetic antigenic sites. (Twining SS, Atassi MZ) J Immunol Methods 1979;30(2):139-51 65 Citations |
| 1 | Interstitial nephritis due to phenytoin hypersensitivity. (Sheth KJ, Casper JT, Good TA) J Pediatr 1977 Sep;91(3):438-41 35 Citations |
| 1 | Reactivity of human brain antiserum with neuroblastoma cells and nonreactivity with thymocytes and lymphoblasts. (Casper JT, Borella L, Sen L) Cancer Res 1977 Jun;37(6):1750-6 20 Citations |
| 1 | Processing of normal antibody-coated sheep erythrocytes by mouse peritoneal macrophages. (Sohnle PG, Sussdorf DH) Immunology 1972 Sep;23(3):361-74 2 Citations |
